Search Results - "Amado, Defne A."

  • Showing 1 - 15 results of 15
Refine Results
  1. 1
  2. 2
  3. 3

    The Importance of Offering Exome or Genome Sequencing in Adult Neuromuscular Clinics by Dratch, Laynie, Bardakjian, Tanya M, Johnson, Kelsey, Babaian, Nareen, Gonzalez-Alegre, Pedro, Elman, Lauren, Quinn, Colin, Guo, Michael H, Scherer, Steven S, Amado, Defne A

    Published in Biology (Basel, Switzerland) (01-02-2024)
    “…Advances in gene-specific therapeutics for patients with neuromuscular disorders (NMDs) have brought increased attention to the importance of genetic…”
    Get full text
    Journal Article
  4. 4

    Gene therapy for ALS: A review by Amado, Defne A., Davidson, Beverly L.

    Published in Molecular therapy (01-12-2021)
    “…Amyotrophic lateral sclerosis (ALS) has historically posed unique challenges for gene-therapy-based approaches, due to a paucity of therapeutic targets as well…”
    Get full text
    Journal Article
  5. 5

    Novel data-driven subtypes and stages of brain atrophy in the ALS-FTD spectrum by Shen, Ting, Vogel, Jacob W, Duda, Jeffrey, Phillips, Jeffrey S, Cook, Philip A, Gee, James, Elman, Lauren, Quinn, Colin, Amado, Defne A, Baer, Michael, Massimo, Lauren, Grossman, Murray, Irwin, David J, McMillan, Corey T

    Published in Translational neurodegeneration (07-12-2023)
    “…TDP-43 proteinopathies represent a spectrum of neurological disorders, anchored clinically on either end by amyotrophic lateral sclerosis (ALS) and…”
    Get full text
    Journal Article
  6. 6

    A single ALS center experience with clinical use of sodium phenylbutyrate‐taurursodiol by Quinn, Colin, Baer, Michael, Amado, Defne A., Kelley, Mary, Elman, Lauren

    Published in Muscle & nerve (01-07-2024)
    “…Introduction/Aims The aim of this study was to examine clinical utilization and discontinuation rates of sodium phenylbutyrate‐taurursodiol (PB‐TURSO) in a…”
    Get full text
    Journal Article
  7. 7

    AAV-Mediated Progranulin Delivery to a Mouse Model of Progranulin Deficiency Causes T Cell-Mediated Toxicity by Amado, Defne A., Rieders, Julianne M., Diatta, Fortunay, Hernandez-Con, Pilar, Singer, Adina, Mak, Jordan T., Zhang, Junxian, Lancaster, Eric, Davidson, Beverly L., Chen-Plotkin, Alice S.

    Published in Molecular therapy (06-02-2019)
    “…Adeno-associated virus-mediated gene replacement is emerging as a safe and effective means of correcting single-gene mutations affecting the CNS. AAV-mediated…”
    Get full text
    Journal Article
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12

    TMEM106B modifies TDP-43 pathology in human ALS brain and cell-based models of TDP-43 proteinopathy by Mao, Fei, Robinson, John L., Unger, Travis, Posavi, Marijan, Amado, Defne A., Elman, Lauren, Grossman, Murray, Wolk, David A., Lee, Edward B., Van Deerlin, Vivianna M., Porta, Sílvia, Lee, Virginia M. Y., Trojanowski, John Q., Chen-Plotkin, Alice S.

    Published in Acta neuropathologica (01-10-2021)
    “…The neurodegenerative diseases amyotrophic lateral sclerosis (ALS) and frontotemporal lobar degeneration with TAR DNA-binding protein-43 (TDP-43) inclusions…”
    Get full text
    Journal Article
  13. 13
  14. 14

    Pattern of distribution and cycling of SLOB, Slowpoke channel binding protein, in Drosophila by Jaramillo, Angela M, Zheng, Xiangzhong, Zhou, Yi, Amado, Defne A, Sheldon, Amanda, Sehgal, Amita, Levitan, Irwin B

    Published in BMC neuroscience (27-01-2004)
    “…SLOB binds to and modulates the activity of the Drosophila Slowpoke (dSlo) calcium activated potassium channel. Recent microarray analyses demonstrated…”
    Get full text
    Journal Article
  15. 15